Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
企業コードSNY
会社名Sanofi SA
上場日Jul 01, 2002
最高経営責任者「CEO」Hudson (Paul)
従業員数84587
証券種類Depository Receipt
決算期末Jul 01
本社所在地46 Avenue de la Grande Armee
都市PARIS
証券取引所NASDAQ OMX - NASDAQ BASIC
国France
郵便番号75017
電話番号33153774000
ウェブサイトhttps://www.sanofi.com/
企業コードSNY
上場日Jul 01, 2002
最高経営責任者「CEO」Hudson (Paul)